Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Managing lipid disorders.

H G Schrott

    Iowa Medicine : Journal of the Iowa Medical Society
    |September 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Physicians often lack experience in managing high cholesterol and triglycerides through diet or medication. While new drugs show promise, their long-term safety remains unknown.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lipid-altering efficacy and safety of simvastatin 80 mg/day: worldwide long-term experience in patients with hypercholesterolemia.

    Nutrition, metabolism, and cardiovascular diseases : NMCD·2001
    Same author

    Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: a randomized, placebo-controlled study.

    American heart journal·2000
    Same author

    Improving prevention systems in primary care practices: the Health Education and Research Trial (HEART)

    The Journal of family practice·2000
    Same author

    Lipid-altering efficacy and safety of simvastatin 80 mg/day: long-term experience in a large group of patients with hypercholesterolemia. World Wide Expanded Dose Simvastatin Study Group.

    Clinical cardiology·2000
    Same author

    Effect of hormone replacement therapy on the validity of the Friedewald equation in postmenopausal women: the postmenopausal estrogen/progestins interventions (PEPI) trial.

    Journal of clinical epidemiology·1999
    Same author

    Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)

    American heart journal·1998
    Same journal

    CONTENT MARKETING How Your Medical Practice Can Benefit.

    Iowa medicine : journal of the Iowa Medical Society·2018
    Same journal

    A NATIONAL UPSET The Remedy Starts Here.

    Iowa medicine : journal of the Iowa Medical Society·2018
    Same journal

    RENEWING PASSION AND PURPOSE IN PRACTICE.

    Iowa medicine : journal of the Iowa Medical Society·2018
    Same journal

    CANDOR PILOT SITE A SUCCESS IMS receives grant tofurther Candor education.

    Iowa medicine : journal of the Iowa Medical Society·2018
    Same journal

    A PRESCRIPTION FOR PROFESSIONAL BURNOUT.

    Iowa medicine : journal of the Iowa Medical Society·2018
    Same journal

    TO MAKE AN END IS TO MAKE A BEGINNING.

    Iowa medicine : journal of the Iowa Medical Society·2018
    See all related articles

    Area of Science:

    • Cardiology
    • Metabolic Disorders
    • Pharmacology

    Background:

    • Hypercholesterolemia and hypertriglyceridemia are significant health concerns requiring effective management.
    • Current clinical practice faces challenges in implementing dietary interventions for cholesterol reduction.
    • Physician experience with lipid-lowering medications, particularly resins and niacin, is limited.

    Purpose of the Study:

    • To review the importance of treating hypercholesterolemia and hypertriglyceridemia.
    • To highlight the challenges physicians face in managing these lipid disorders.
    • To address the current limitations in therapeutic approaches and the need for further research on emerging treatments.

    Main Methods:

    • Literature review on the treatment of hypercholesterolemia and hypertriglyceridemia.

    Related Experiment Videos

  • Analysis of physician experience with dietary and pharmacological interventions.
  • Assessment of the current landscape of lipid-lowering drugs and future prospects.

    • Main Results:

    • Many physicians lack expertise in prescribing cholesterol-lowering diets.
    • Limited physician experience exists with established lipid-lowering drugs like resins and niacin.
    • Newer medications are under development, but their long-term safety profiles are undetermined.

    Conclusions:

    • There is a critical need for enhanced physician education and training in managing dyslipidemias.
    • Current therapeutic strategies are hampered by a lack of clinical experience and uncertainty regarding novel drug safety.
    • Further research is essential to establish safe and effective long-term treatments for hypercholesterolemia and hypertriglyceridemia.